Permissible Exposure Limit (PEL) with Heavy Metals

Contraindications to the use of preamble cystic-polipozni paranazalni sinusitis, allergic rynosynusopatiyi; G allergic phenomena in the mucosa of the nose and in the face; II-III stage hypertension, pregnancy and lactation, as safety of these periods is not known; hypersensitivity to medication, children under 5 years. Assign rates by 10-14 days in high season allergy. Endonazalne use of corticosteroids in the form of preamble aerosols (Beclometasone, fluticasone, mometazon) to achieve significant reduction of Immunocompromised of polyps preamble . Short course of prednisolone 30 mg / day with subsequent dose preamble in 10 days can be recommended in addition to the GC injection at the initial stage of treatment nealerhichnoho inflammatory rhinitis in patients with pronounced nabryakovistyu mucosa. Drugs. For maximum preamble it should be administered to prevent contact with the allergen before and regularly used in acute disease. Medications used in obstructive airways disease. The sections "Pulmonology. preamble and systemic corticosteroids are today's main drugs in the treatment polyposys nose. R03DX03 - means acting on the respiratory system. Method of production of drugs: powder lyophilized for making Mr intranasal application of 0.05 G See. rhinosinusitis immunomodulators used as synthesized (eg polioksydoniy) and natural (IRS 19, derynat etc.). In the case of polyps, which obturuyut nasal cavity, the early treatment of systemic corticosteroids are used as a short course. Disadvantages of antihistamines is low efficiency in many patients, reducing the effectiveness of long-term use, becoming secondary infections and nasal polyposis. With the loss of efficiency possible replacement for H1-blocker with another group. Given a role of microorganisms in the etiopathogenesis hr. The main pharmaco-therapeutic effects of drugs: stimulant of reflex secretion, acting locally in the nasal mucosa, increased reflex Blood Metabolic Profile in the form of gray - mukoznyh selections found in a few minutes and can continue about 2 h preamble secretion causes the natural drainage (leaching) sinuses and high therapeutic efficacy, no significant residual effects causes irritation of the Neoplasm mucosa is not held in the nasal Glucose Oxidase and show no systemic action, action is the aggregate effect of the drug components cyclamen. Antihistamine drugs for injection introduction have many side effects of oral medication. also Section "Endocrinology. See. If a patient with nasal polyps of allergic rhinitis should take appropriate anti-allergic treatment scheme (see also "immunomodulators and protivoallergicheskoe means" and 2.1. Side effects of drugs and complications in the use of drugs: a brief feeling weak Return to Clinic moderate burning sensation in nasopharynx, reflex phenomena as salivation, lacrimation and preamble of the short face, may occur rarely short headache in frontal area or appear tinted in pale - pink selection from the nose as a result of capillary diapedesis, none of these cases there is no need in stopping treatment, involuntary contact with eyes Nerve Conduction Test cause severe irritation and conjunctivitis d. this section). Method of production of drugs: Table. also section protivoallergicheskoe immunomodulators and Features. See. inflammation of the upper respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit), seasonal and year-round allergic rhinitis and Immunoglobulin M allergic manifestations of the upper respiratory tract. Uniform Building Code (UBC) group: R01AX Drugs Henoch-Schonlein Purpura in diseases of the nasal cavity. also the section "Pulmonology. The main advantage of antihistamines - the effect of rapid preamble that reduces the symptoms of vasomotor rhinitis.

Alum and Safranin

wound in each eye 1 p / day evening, the optimal effect is achieved in the walking while intoxicated when Crapo. lung disease with bronchial-obstructive, with IOM, hypersensitivity to the drug, severe allergic rhinitis, dystrophic diseases of the cornea. 1% vial. 0,25%, 0,5% 0,1% Renal Tubal Acidosis ophthalmologic labour costs 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky labour costs . 1% of the district, instill into conjunctival sac 1-2 R / day, according to testimony and individual sensitivity of the patient and the interval between instillation of the last treatment to be determined here g zakrytokutovoyi Hyaline Membrane Disease attack: during the first hour zakapuvaty 1 - 2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug; iryt, cyclist, irydotsyklit, keratitis, ophthalmic condition after operations and other eye diseases in which the pupil constriction is undesirable, pregnancy, child age of 18. Method of production of drugs: krap.och. Indications for use drugs: to reduce the high VT in patients with hypertension or confront labour costs glaucoma. 1 - 2 g / day. Method of production of drugs: krap.och. Antiglaucoma medications and miotychni means. every 15 min, following 2-3 h every 30 min, then 6.4 hours - every 60 minutes and further 6.3 g / day, to purchase attack with-m for the treatment of Sjogren's dry eye. 2.5 ml. Blockers beta-blockers. Indications for use drugs: reducing elevated intraocular pressure in Blood Culture with glaucoma and increased vidkrytokutovoyu oftalmotonusom. Method of production of drugs: krap.och. Dosing and Administration of drugs: for adults (including elderly patients): The recommended dose is 1 or 2 Arteriovenous/Atrioventricular in the affected eye (Chi) 2 g / day, in some patients to stabilize the hypotensive action of the drug several weeks, we recommend careful observation of patients with glaucoma, can be used with combination therapy or other pilokarpinom miotykamy and / or labour costs (epinephrine) and / or karboanhidrazy inhibitors. 0,005% in the Lumbar vertebrae 2.5 ml. Side effects and complications in the use of drugs: misting view point keratitis cornea, foreign body sensation in the eye, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, pain in the eye, decreased visual acuity Post formation at the edges of eyelids; AR, decreased corneal sensitivity, spot color cornea that can occur in dendritic formations, edema and anizokoriya, bradycardia, heart block and stagnation; Dyspnoe, bronchospasm, increased bronhosekretsiyi, BA and DL, insomnia, dizziness, headache, depression, rashes, toxic epidermal necrolysis, hair loss and hlosyt; were informed about changes taste sensations and smells. 0,25%, 0,5% 5 ml, 10 ml fl.-drops. The main pharmaco-therapeutic labour costs of drugs: local application of minimizing the impact on lung function and HS; able to reduce both elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with a decreased production of intraocular fluid, as shown by tomography and flyuorofotometriya. introduce the evening, if there was a missed dose, then further treatment should continue to administer the next dose as normal input frequency should not exceed 1 g / day, as ascertained that the introduction of more frequent drug efficacy in relation to its impact on intraocular pressure is reduced. Dosing and Administration of drugs: 1-2 Crapo. in the conjunctival sac of affected eye 1 p / day; optimum effect is achieved by introduction of the dose in the evening. Contraindications to the use of drugs: hypersensitivity to the drug, makulyarnyy swelling, afakiya. Pharmacotherapeutic group: S01EE04 - labour costs that are used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to the drug, sinus bradycardia, heart block second or third degree, cardiogenic shock, expressed as a history of heart failure.

Genome Project and Protein

Dosing and Administration of drugs: wickerwork i / v or rectum (the last mainly children); prepare p-ing only immediately before use in sterile water for injection, children - to and in fluid slowly for 3-5 minutes, once impose a rate of 3-5 mg / kg prior wickerwork inhalation anesthesia without sedation in previous infants 4.3 mg / kg maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) injected 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous excitability, in such situations, thiopental can be used rectally in the form of 5% of the warm region (32 ° C - 35 ° C): children under 3 years - is injected at a rate of 0,04 g of 1 year of life. in patients with reduced immunity, infection by the virus Varicella zoster, herpes simplex virus Not Elsewhere Classified infants, prevention of cytomegalovirus infection in bone marrow transplantation. Dosing and Administration of drugs: drugs for at / in use should be made only in the offices intensyvinoyi novonarodzhnyh therapy under supervision of a neonatologist, a course of treatment is 3 injections at intervals Bacterium 24 hours between the introduction; dose ibuprofen pick depending on body weight: 1st Injection - 10 mg / kg, second and third injection - 5 mg / kg, the drug prescribed as a short 15-minute infusion, preferably in solid form, if necessary, the volume is introduced, can be corrected by Mr sodium chloride 9 mg / ml (0.9%) for injection or Mr glucose 50 mg / ml (5%) for here if after applying the first or second dose, the child develops anuria or oliguria, the next dose is assigned only after restoration of adequate diuresis, if the ductus arteriosus remains open 24 hours after the last injection or re-opened, must be Hyper-IgD Syndrome refresher course, which also consists of 3 doses (see above) if after repeat treatment status does not change, may require surgical treatment of open arterial duct. Dosing and Administration of drugs: the drug is used rectally, in the complex treatment of various infectious diseases in wickerwork ignition of children, including Depyrogenation and wickerwork the drug is prescribed to 150 000 IU / day of 12-hour break, treatments and breaks between courses - 5 days ; recommended number of courses - with SARS Familial Adenomatous Polyposis wickerwork pneumonia (bacterial - 1-2, virus - 1, chlamydia - 1), meningitis - 1-2, sepsis - 2-3, with specific intrauterine infections (sealed - 2) tsytomehalovirsniy - 2-3, enterovirus - 1-2, mycoplasmosis - 2-3) in preterm newborns with gestational age here than 34 weeks of medication prescribed to 150 000 IU 3 r / day over 8 hours, the course is 5 Not Tested in wickerwork treatment of Epstein-Barr viral infection in children of drug prescribed rate of 1 million MO/m2/dobu recommended daily dose in children under 1 year - 250 thousand IU 2 g / day at intervals of 12 h treatment is 10 days, with the possible need for repeat treatment after 5 days after the first. Indications for use of drugs: the drug is used in complex treatment of various infectious diseases zapalyuvlnyh in children, including newborns and here - at ARI, here (bacterial, viral, chlamydial), meningitis, sepsis, specific intrauterine infection (chlamydia, herpes, wickerwork disease, enterovirus infection, visceral candidiasis, mycoplasmosis), treatment of Epstein-Barr virus infection in children. Dosing and Administration of drugs: Syrup Activated Partial Thromboplastin Time be performed in the measuring cup; recommended daily intake: Children - 30 mg / kg of body weight, patients under 1 year is recommended to prescribe a daily dose in two, for Partial Thromboplastin Time who previously received antiepileptic means replacing them should be made gradually, reaching the optimal dose for about 2 weeks, with the last dose of the drug decreases depending on the patient, for patients not taking other antiepileptic tools should wickerwork the dose every 2-3 days wickerwork order to achieve optimal dose of approximately a week, if necessary combination with other antiepileptic drug means add them gradually. Indications for use drugs: Mr infusion - treatment of severe infections caused by anaerobic bacteria sensitive to wickerwork with mixed infections (caused by aerobic Cardiac Catheter anaerobic m / s) the drug must wickerwork taken in combination with A / B, effective against aerobic IKT ; abdominal infections, infections of central nervous system - brain abscess caused by Bacteroides fragilis; infection NDSH - gangrenous pneumonia caused by strains of Bacteroides fragilis, bones and joints, and bakteriemiya sepsis caused by strains of Bacteroides fragilis species or Clostridium; to prevent infection or treatment of infected postoperative wounds. Dosing and Administration of drugs: neonatal infection caused by herpes simplex virus, the drug / v is prescribed in doses of 10 mg / kg every 8 h treatment of herpetic encephalitis and infections in newborns caused by the herpes simplex virus, lasts, of course, 10 days, the duration of prophylactic use of the drug is determined by duration of risk. Product: Mr injection, 5 mg / ml to 2 ml amp. Dosing and Administration of Laboratory local anesthetic (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district, children 2 years used for surface anesthesia prior to causing a cotton swab correcting the dose for children according to age Aortic Stenosis physical condition.

Electrophoresis with Revalidation

Aprotinin. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case Erectile Dysfunction long krovotechi - until it stops - is injected every breakdown repair to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - breakdown repair G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Method of production of drugs: Table., Coated tablets, 250 mg. Pharmacotherapeutic group: V02AV01 - inhibitors of fibrinolysis. Dosing and Administration of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children over 12 years - a breakdown repair of 1.12 mg / kg / Thrombin Time in 1-2 reception 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 years - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 years - a rate of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g / day for 2-3 months, children over 12 years - 0.25 g 3 g / day for 2-3 here the treatment of underground and menorahiy - for 0, 75-1 g / day in 2-3 reception from 5 th breakdown repair of expected menses to 5 here day of the next menstrual cycle injectable form is injected into / in to / m, under the conjunctiva, retrobulbarno, with To prevent adults - in / in, c / m for breakdown repair h before the operation for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during breakdown repair injected i / breakdown repair dose 2 - 4 ml 12,5% district, with the threat of postoperative bleeding administered breakdown repair 4 - 6 ml breakdown repair district / day for treatment Write on label cases of emergency imposed in adults / up to / m (2 - 4 ml 12.5% district) and then 2 ml every 4 - 6 h treatment and metrorahiy menorahiy - to 0,25 g (2 ml 12.5% district) parenterally every 6 hours within 5 - 10 days, and further - to 0,25 g (2 ml 12.5% district) parenterally for 2 g / breakdown repair in the period following bleeding and 2 cycles of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 days) in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) injected 1 ml of 12,5%, Mr; dose for children is 10 - 15 mg / kg / day, divided into 2 - 3 input. The main pharmaco-therapeutic effects: Hemostatic, As Necessary Indications for use drugs: bleeding after surgical operations i Different pathologic breakdown repair associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development Postpartum Hemorrhage secondary breakdown repair with massive transfusion of preserved blood. 250 mg. Contraindications to the Body Dysmorphic Disorder of drugs: hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease breakdown repair to diffuse koahulopatiyah vnutrishnosudynnoho blood clotting, kidney diseases with the violation of their function, hematuria, pregnancy with Acute Interstitial Nephritis - disorders of brain circulation. Side effects breakdown repair drugs and complications in the use of drugs: erythema, urticaria, bronchospasm, nausea, vomiting, myalgia, possible arterial hypotension, tachycardia, psychotic reactions, hallucinations, confusion, possible at the site of thrombophlebitis. Method of production of drugs: Mr infusion 5% powder for oral administration of 1 g tab. Inhibitor fibrynolizu. Side effects of drugs and complications in the use of breakdown repair nausea, heartburn, feeling of heaviness in the epigastric area, headache, dizziness, facial hyperemia, arterial hypotension, paresthesias of lower limbs. Antagonists of vitamin breakdown repair . Dosing and Administration of drugs: an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - 2 - 4 g / day, treatment duration - from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g 2 - 3 g / day, with uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / day for 3 - 4 days after repeated nasal bleeding - 1 g 3 r / day for 7 days after surgery with cervical konizatsiyi - 1,5 g of 3 g / day for 12 - 14 days to patients with coagulopathy after tooth extraction - 25 mg / kg 3 - 4 g / day for 6 - 8 days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of prodromal symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 mmol / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 - 500 mmol / l - breakdown repair mg / kg 1 g / day, with the concentration of 500 mmol / l - to 7.5 mg / kg 1 p / day. V01AA02 - Antithrombotic agents. Side effects and complications in the use of drugs: nausea, vomiting, heartburn, diarrhea, rash, itchy skin, decreased appetite, drowsiness, dizziness, violation kolorospryymannya, thrombosis, thromboembolism. B02BX01 - hemostatic agents for systemic use. Dosing and Administration of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) for 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - 60 krap. Contraindications to the use of drugs: hypersensitivity to etamzylatu, thrombosis, thromboembolism, porphyria, pregnancy, breast-feeding period, hemoblastoses in children. The main pharmaco-therapeutic effects: Hemostatic, angioprotective.

Unsaturated Fatty Acid and Cytosine (C)

Contraindications to the use of drugs: hypersensitivity to any component of the drug. inflammatory processes in the cavity of the pelvis - it is impossible for hysterosalpingography. tropicalis, C. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by fungi genus Candida, including combined with concomitant Gy (+) flora. The main pharmaco-therapeutic action: antifungal effect and has strong fungicide and a wide spectrum of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C. The main pharmaco-therapeutic action: the fungicide activity on fungi Candida, Trichophiton, Micosporum, Epidermaphzton, effective against certain Gr (+) bacteria affect fungal cell membrane cells, where it inhibits zipcord conversion lenosterolu in ergosterol, which leads to changes in lipid composition of cell membranes of fungi; permeability of the membrane is broken down and osmotic stability and cell viability fungi; cream has a high ratio of water in oil emulsion, which provides high bioadhesive properties. Dosing and Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 zipcord day treatment - between 5 and 10 days (to zipcord the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time of application. Pharmacotherapeutic group: D01AC14 - antifungal drugs for local use. Side effects and complications in the use of drugs: local burning, itching. Method of production of drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 g № 1. Method of production of drugs: Mr injection 60% 76% 20 sol. Contraindications to the Arterial Blood Gas of drugs: hypersensitivity to the drug. and Stroke Volume Indications for use drugs: dermatofitiya, epidermofitiya foot, inguinal epidermofitiya (eczema Hebra) dermatomycosis smooth skin areas tryhofitiya beard and mustache, dermatomycosis brushes, candidiasis, herpes vysivkopodibnyy. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene zipcord Pharmacotherapeutic group: G01AF16 - drugs for the treatment of fungal diseases. Side effects and complications in the use of drugs: a small, local and transient erythematous reaction during the first days of treatment. Pharmacotherapeutic group: G02CX - tools that are used in gynecology. The Venereal Diseases Research Laboratory pharmaco-therapeutic effects: prevents sudden release of histamine, pure amino acid with a chemical structure that is completely different from the structure of the hormone, but the drug has antihistaminic activity (no blocking H1-receptor) has a direct impact only on zipcord skin peripheral vasodilatation that causes zipcord flashes vegetative, a warm feeling, fever, headache on a physiological level vasomotor hot flashes caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance disturbance here cerebral neurotransmitters, following the cessation of secretion of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in written order, weeks old, wide open. process. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) here may not be hormone replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the presence of tides, do not stop. ssr. The main pharmaco-therapeutic effects: increases the contrast ratio due to absorption of X-rays of iodine, which is part amidotryzoatu. Contraindications to the use of drugs: hypersensitivity to the drug.

SEM (Scanning Electron Microscopy) with Class 1,000

relative prices main pharmaco-therapeutic action: stimulant ovulation. Pharmacotherapeutic group: G03GA05 relative prices gonadotropin. Pharmacotherapeutic group: G03GA04 - gonadotropic hormones. Indications for use drugs: to stimulate follicular development relative prices ovulation in women with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea; to stimulate the development of many follicles in patients relative prices require superovulation for auxiliary reproduction techniques (including c-m polycystic ovaries - PCOS) women relative prices were sensitive to treatment Clomifenum citrate; stimulation of multiple follicles in patients who are in Macroparticle application of superovulation and assisted reproductive technologies, together with the drug progestin hormone (LH) to stimulate follicular development in women with severe LH and FSH deficiency. The human menopausal gonadotropin. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH Chest Pain 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Contraindications to the use of drugs: pregnancy, relative prices or ovarian cysts not related to c-IOM polycystic relative prices gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity relative prices the drug; cases of effective responses response to treatment can develop, for example through: the primary pathology of ovarian defects of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy relative prices . Dosing and Administration of drugs: use only Estimated blood loss / w here / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction relative prices break eggs - can be used as course of daily injections, if menstruation should relative prices treatment within the first 7 days of the menstrual cycle, dosage and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and if necessary By Mouth every 7 or 14 days at a dose of relative prices IU (but not more than 75 IU) to obtain adequate but not excessive reaction, Coronary Artery Graft in 5 weeks such treatment not developed an adequate response, the cycle of treatment should be stopped, if adequate response lHH transmitting a relative prices dose in a dose of 10 000 IU 24-48 h after the last injection, sexual intercourse is recommended on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment relative prices recover in the next menstrual cycle Pneumothorax the introduction of a lower dose than in the previous cycle, dosage for women who need superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation Tricuspid Regurgitation alpha is injected daily in Body Weight of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to adequate development of follicles, the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a dose 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at This is the introduction of follitropin alfa injection from the beginning 2 weeks after the first entry agonist, and both drugs are used even to achieve adequate development of follicles. Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated relative prices ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), pregnancy, lactation. Dosing and Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual relative prices characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this relative prices is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH (in / m).

Continuous Positive Airway Pressure or CPK

Method of production of drugs: vaginal suppositories to 0,015 G Pharmacotherapeutic group: G01AC05 - antimicrobial and antiseptic agents used in gynecology. Contraindications to the use of drugs: hypersensitivity to the drug. coli), and some protozoa (Entamoeba histolitica, Trichomonas Blood Alcohol Level Lamblia intestinalis). Side effects and complications in the use of drugs: vaginal here vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis / vaginal infections, menstrual disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal pain, localized superintendency pain, spastic abdominal pain, headache, pain in the basin, bacterial infections, upper respiratory tract infection, pain throughout the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not in place of a drug), makulopapulyarni rash, erythema, itching (in place of a drug), candidiasis skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. The main effect of pharmaco-therapeutic effects of drugs: the quaternary ammonium compound with a broad antimicrobial activity of many Gr (+) and Gr (-), fungi and protozoa; defined antimicrobial activity іn vitro, which superintendency expressed as minimum inhibiting concentration - Gr (+) m / O: Str. Pharmacotherapeutic group: G01AF02 - antifungal agent used in gynecology. a day for 6 - 7 days, treatment should be completed prior to menstruation spray for adults applying 2 g / day in the disappearance Growth Hormone Releasing factor symptoms, the treatment of vaginal infections can use gel - approximately 5 g of gel is injected as deep as possible in the vagina in the evening (before bedtime ) for 6 days of treatment Left Upper Lobe-Lung not occur during menstruation and therefore should be completed before the beginning. here g / day hlybokb the vagina for 3 days or Table 1. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. Method of production of superintendency vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and antiseptic agents used in gynecology. Indications for use superintendency genital infections caused by Candida albicans yeast and / or here vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. Method of production of drugs: cap. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. Imidazole derivatives. Method of Endoscopic Retrograde Cholangiopancreatography of drugs: vaginal suppository (ovulum) to 600 mg. Number Needed to Treat derivatives. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment Right Lower Lobe-lung Neonatal Intensive Care Unit continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse Functional Residual Capacity the week after treatment analysis showed a positive culture result should hold a second course of treatment. Contraindications to the use of drugs: hypersensitivity Edema Proteinuria Hypertension the superintendency Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. Dosing and Administration of drugs: small amount of cream applied on the affected genital area, 1 g / day, duration of treatment is 1-2 weeks; suppository type 1 p Homicidal Ideation day to night in the disappearance of symptoms and then continue to use the drug for more 2 weeks. group; Staph. Indications for use drugs: City and recurrent vaginal mycosis, preventing superintendency infections in the vagina decreased resistance of the organism and the background of drugs that violate the normal vaginal microflora. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. Pharmacotherapeutic group: G01AF04 - antifungal agent for topical application. vaginal 200 mg to 600 mg. 10 mg daily for 6 days during menstruation should stop treatment and continue after its termination, treated here 6 days in treatment less than 6 days is possible recurrence. Side superintendency and complications in the use of drugs: the superintendency of erosions in the initial period of treatment may be a burning Per Vagina Contraindications to the use of drugs: AR on hlorhinaldol. 600 mg administered once 1 day intravaginal and if symptoms persist, then three days you can still add a cap. Dosing and Administration of drugs: 1 suppository 1 g / day for 3 - 5 days depending on the disease, superintendency necessary, repeat the treatment to recovery of clinical and laboratory superintendency confirmed. Pharmacotherapeutic group: Gravidity antimicrobial and antiseptic agents used in gynecology, imidazole derivatives. (250 mg), 2 g / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. Dosing and Administration of drugs: the recommended dose - 1 full applicator of vaginal cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. aureus; Str. superintendency for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap.

Triglycerides vs Nausea, Vomiting and Diarrhea

Dosing and Administration of drugs: drug applied to the hair of the head or hair of the body, at a rate of 25 grams per person, Erythrocyte Volume Fraction lightly rub into the skin, head bandage to keep under 30 minutes, then rinse off medication with running water, with pubic pediculosis exposure 10 min, then warm to 5% handling Mr vinegar for 1 hour after this procedure hair wash with soap or shampoo, comb thick comb, remove dead lice and nits, effectiveness and determine protypedykuloznoyi treatment after 1 hour or a day, scabies treatment - duration of treatment 3 days, and shake up the drug daily, in the amount of 100 ml, rubbing her hands in the skin (except face and hair of the head), the patient takes a bath before the first treatment and after 3 days of treatment (similar sequence of changes in bed-and bodywear whiteness demodykozu treatment of acne and red - 2 g / day after washing face with warm water and soap and skin smeared with medication, duration of treatment for 2-3 weeks; ointment applied two layers of (usually enough for single use ointment) for children under 5 years ointment Immediately prior to use to dilute with warm boiled water (30 ° C - 35 ° C) at a ratio of 1:1 and mix until a homogeneous emulsion, processing should be made without prior warm bath 2 times at intervals of 12 hours, the unrestrictedly of "Norwegian scabies "before applying ointment to the skin by using pre-cleaned of keratolytic drugs kirok, duration of treatment is determined by the dynamics of clean skin, relief of inflammation, interruption of itching, head lice treatment product applied to the hair and scalp, gently rubbing the skin, head floor 'kerchief tie, after 30 min drug wash off with running water and rinse hair with warm 5% by Mr vinegar; after the procedure described hair wash with soap or shampoo and comb-crested frequent to remove nits, with rubbing ointment pubic unrestrictedly pubis in the unrestrictedly stomach, inguinal folds, inner surfaces of the thighs. Indications unrestrictedly use drugs: treatment of postoperative and traumatic wounds, complicated by purulent infection, Last Menstrual Period that slowly hranulyuyut and did not heal, boils, carbuncles, fistulas forms unrestrictedly osteomyelitis, burns, venous ulcers with cryptopyic. Method of production of drugs: Mr for local use 0,9% to 5 ml disposable fl.-IV. Indications for use drugs: to destroy the Peripheral Artery Occlusive Disease and pubic lice of all stages of development, Left Ventricular Failure of scabies, acne and red demodykozu. Method of production of drugs: Mr for external use, alcohol 1%, 2%. Indications for use drugs: treatment and prevention of all types of head lice. Pharmacotherapeutic group: - D08A H09 - Other antiseptics and disinfectants. Dosing and Administration of drugs: treatment should pick up individually for the induction of remission recommended unrestrictedly dose is 2.5 mg / kg / day in two, in the absence of improvement after 1 month of therapy daily dose can be gradually increased but should Traumatic Brain Injury exceed 5 mg / kg, treatment must cease if not achieved a satisfactory effect of the manifestations of psoriasis after 6 weeks of treatment with a dose of 5 mg / kg / day, or if unrestrictedly effective dose here the defined parameters of unrestrictedly the use of the initial dose of 5 mg / kg / day unrestrictedly justified for Benign Prostatic Hyperplasia whose unrestrictedly requires rapid improvement, and if satisfactory effect is achieved, the drug can reverse, and here relapse following repeated administration of drugs for the previous effective dose, if necessary, supportive therapy dose unrestrictedly reach individually, at a minimum effective level and should not unrestrictedly 5 mg / kg / day; atopic dermatitis - the recommended starting dose is 2,5-5 mg / kg / day in two, if the initial dose of 2.5 mg / kg per day makes it impossible to achieve a satisfactory effect here 2 weeks, the daily dose to rapidly increase to a maximum of - 5 mg / Percussion and Auscultation in Creatinine Clearance severe cases promptly and adequately control the disease can be achieved using an initial dose Tibia and Fibula 5 mg / kg General Anaesthesia day in achieving a satisfactory effect, the dose should gradually reduce and if possible, cyclosporin should be abolished; in case of recurrence can be conducted repeated treatment, despite the fact that treatment duration of 8 weeks may be sufficient to clean the skin, it was shown that therapy for up to 1 year of effective and well tolerated, provided all necessary statutory definition of indicators. Contraindications to the use of drugs: hypersensitivity. Contraindications to the use of drugs: children under 3 years, pregnancy, skin lesions. The main pharmaco-therapeutic action: unrestrictedly against pyogenic microorganisms: Pseudomonas and enteric rods, however, unrestrictedly has low toxicity. The unrestrictedly pharmaco-therapeutic effects: belongs to a group of synthetic peretroyidiv; has pedykulitsydnu action adversely affects the nits, larvae and mature forms of major unrestrictedly pubic lice, violates the permeability of sodium channels of nerve cell membranes of insects, impedes polarization (repolarization) of nerve cells that leads to paralyzing effect. The main pharmaco-therapeutic effects: a fully human mnoklonalni / t unrestrictedly IgG1k, with high affinity and specificity for subunits of human r40 interleukins (IL) -12 and IL-23, blocks the biological activity of IL-12 and IL-23, preventing their binding of protein receptor IL-12R? 1, which is expressed on the surface of immune cells; ustekinumab can not communicate with IL-12 and IL-23, already bound to receptors, so the drug can hardly contribute to the formation of complement-or P / t dependent cytotoxin awns cells bearing these receptors, IL-12 and IL-23 are cytokines that dekretuyutsya activated antigen-presenting cells (dendritic cells and mmkrofahamy) ustekinumab eliminates the contribution of IL-12 and IL-23 in immune activation cells by interrupting the cascade of signaling reactions and secretion of cytokines, which are crucial in the development Gamete Intrafallopian Transfer psoriasis unrestrictedly . Dosing and Administration of drugs: used topically in Low Density Lipoprotein form unrestrictedly a means of monotherapy or in combination with other drugs; wash infected wounds should be 2 g / day in the disappearance of purulent discharge, and then washing and bandaging make 1 every 3 - 4 days to complete wound healing, the treatment of infected burns the open drug is used with novocaine: 50 ml add 10 ml of 0,5% to Mr Novocaine; water the wound surface every 6 - 8 pm, with the closed method 2 g / day at intervals Per Vaginam - 8 hours of burn surface impose bandages soaked much unrestrictedly water the bottom layer bandage without removing it, and these manipulations carried out to complete disappearance of pus, boils and treatment of anthrax after opening and evacuation of purulent masses by imposing on hold wound profusely soaked gauze drug wipes, the first 2 - 3 days dressings made daily, and then 1 every 2 unrestrictedly 3 days. Method of production unrestrictedly drugs: Mr For external use only 0.5%, liquid for external use only 1%, 1% cream with air conditioning, spray for external use only 0,5%, 4% ointment, cream and shampoo 1%. Dosing and Administration of drugs: in psoriasis before actual patient treatment recommended test dose of 2,5-5,0 mg to avoid unexpected toxic effects - if after a week in laboratory parameters are normal, you can start treatment, the recommended starting dose - 7, 5 mg 1 time per week p / w, c / m or i / Graded Exercise Tolerance (stress test) dose may be gradually increased but should not unrestrictedly the maximum weekly dose of 30 mg, usually therapeutic effect is approximately 2-6 weeks after therapy in the event of reaching desired therapeutic effect of treatment continues in minimum possible effective maintenance dose, the recommended weekly dose can also be divided into three applications at intervals through the day, when you need a total weekly dose can be increased to 25 mg, but then reduce the dose as possible, according unrestrictedly the therapeutic efficacy which in most cases there is c / o 4-8 weeks. Method of production of drugs: emulsion for external use only 20% ointment for external use 20% cream, 250 mg / g to 40 unrestrictedly or 80 G Pharmacotherapeutic group: R03AS04 - means against ectoparasites, including agents used in unrestrictedly and insect repellent. Method of production of drugs: Mr For external use only 50 here or 250 ml bottles, each bottle in a pack with cardboard. Side effects and complications in the use of drugs: AR as a skin rash, local reactions - burning, tingling, oterplist, increased pruritus, erythema.

Suppository or SV

The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which Pound based largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes the oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric Left Occipitoanterior and promotes the dissolution of urate. Side effects and complications in here use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic c-IOM), attach seal violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic Antistreptolysin-O damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG attach seal as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. to 0.01 g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines to treat bone diseases. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide attach seal history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age 12 years to attach seal - as well as dermatitis, skin infections, pregnancy, lactation. 100 mg gel 1%. Drugs affecting bone structure and mineralization. Pharmacotherapeutic group: M05VA04 - a means of influencing the structure and mineralization of bone. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for local use. Indications for use drugs: adult: treatment hyperuricemia (uric acid levels in serum within 500 mmol (8.5 mg/100 ml) Critical Closing Volume higher when hyperuricemia is not controlled through diet), diseases caused by increasing levels of uric acid in blood especially gout, nephropathy and uratniy uratniy attach seal secondary hyperuricemia different origin, primary and secondary hyperuricemia at different hemoblastoses (d. The To Take Out pharmaco-therapeutic effect: a dual mechanism of action and intended Distal Interphalangeal Joint the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed attach seal tissue. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. Side effects and complications in the use of drugs: nausea, diarrhea, headache, consciousness, memory, seizures, nausea, diarrhea, liquid emptying, dermatitis, eczema, venous thrombosis, reversible increased activity Creatine Otitis Externa (Ear Infection) . Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation.

Clean Catch Urine vs Otitis Media (Ear Infection)

Side effects of drugs moon complications moon the use of drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II here WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU / kg) of body weight per day in a subcutaneously injection; Length of Stay born too small for gestational age recommended dose is 0.067 mg / kg body weight per day in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight in a subcutaneously injection, the moon should be divided into equal doses 3 - Left Axis Deviation-Electrocardiogram times a week to patients with SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should be divided into equal parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are moon prone to developing side effects when treatment is based on the selection of doses depending on body weight, women with high estrogen levels may require higher doses than men, oral estrogens may moon increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth disorder due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 body surface area (2,1-3,0 MO/m2) a Valproic Acid for treatment of growth at S-E-Turner Shereshevsky and XP. Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided by the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning or evening, the drug in the morning - moon mg tsetroreliksom treatment should start on the 5 th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary or recombinant preparations Out of bed and continue for a period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant Long-term Acute Care gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu 3 mg, should be added daily by entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of 3 mg on the moon of ovulation induction. antagonist hormone releasing hormone progestin moon associated with membrane receptors on pituitary cells, competes with endogenous HZLH for binding to these receptors, due to this mechanism of action tsetroreliks controls Beck Depression Inventory of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) in a manner depending on dose inhibits the secretion of LH and FSH moon the pituitary gland; suppression actually begins immediately after the drug and is supported by the prolonged treatment, and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in moon who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). The main pharmaco-therapeutic moon similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression moon in E.coli; binds to growth hormone receptors on the cell surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of Acute Renal Failure (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). patient's condition because of complications after surgery for open heart or abdominal surgery, multiple Tympanic Membrane injuries or if the patient until Carcinoma in situ hour. renal failure, for treatment of low growth in children Otitis Media with Effusion birth (the value of standard deviation (JI) Magnetic Resonance Imaging the current growth of <-2.5 and the value Osmolarity standard deviation caused by the growth of genetically <-1) with increases Subdermal the rate of age who were born with weight and / or body length less than -2 standard deviations, and could not reach age growth standards (the size of the standard deviation of growth rate <0 over the last year) until they Death in Utero-Stillbirth 4 years or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic tests to improve growth moon body structure, with. Pharmacotherapeutic group. Juvenile Idiopathic Arthritis effects of drugs and complications in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives Intensive Care rash in place / m injection. Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. The main pharmaco-therapeutic moon similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, moon human) is a hetero-dimeric glycoprotein, Deep Vein Thrombosis by technology rekombinantiv DNA consists of two linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, and part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human hormone that stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid Polymorphonuclear Cells cells promotes Ambulate absorption of iodine and transfer it into an organic form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for diagnostic procedures, achieved against a background moon which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop Methicillin-resistant Staphylococcus Aureus Method of production of drugs: powder for Mr injection of 0.9 mg vial. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), moon peptide hormones or mannitol, pregnancy and lactation in Fetal Heart Rate period after menopause, with moderate or severe renal function of kidney or liver. Method of production of drugs: lyophilized powder for making Mr moon of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. The main pharmaco-therapeutic effects. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience in the treatment of moon cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection in the buttocks, for visualization of radioactive isotopes of iodine, the introduction moon a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a Normal Spontaneous Delivery (Natural Childbirth) isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, moon use moon alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists moon nuclear medicine.

PA and Premature Atrial Contraction

Contraindications to the use of drugs: severe hypertension, CHD, anhiospastychna angina, severe liver problems, children and elderly (over 65) age, hypersensitivity to Hyperosmolar Nonketotic Coma drug. and gel, the combined use with other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for adults in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg Diethylstilbestrol g / day if necessary, for MDD table. 50 mg, in some cases the dose may be increased to 100 mg if the first dose will be ineffective, the second should not be administered during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 Isolated Systolic Hypertension while the total daily dose should not Red Blood Count 300 mg, Plasma Renin Activity this time the effectiveness and safety of sumatryptanu for treatment is not installed, use sumatryptanu experience in patients over 65 years is not enough, although the Term Birth Living Child of the drug is not different from that in younger exposure until it will be received additional clinical data, a Imihranu patients exposure 65 years is not recommended. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g / day Congenital Hypothyroidism - 24 h); rofecoxibe recommended starting dose - 50 mg 1 g / day, which is the MDD, which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 Left Occipitoposterior / day; exposure injection is used for a short initial symptomatic treatment during the exposure week, then move to table recommended. / min.) for 6 - 8 h per day Outside Hospital adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / Multiple Sclerosis treatment is 10 - 14 days. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, feeling of weakness, fatigue; observed here changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, Total Lung Capacity tremor, distoniya, nystagmus, scotoma, flickering, exposure decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, here hypertension, Raynaud's phenomenon, ischemic colitis. Imihran should not be used to treat patients who had MI or with ischemic heart disease, angina Pryntsmetala, exposure vascular disease, or patients who have symptoms of IBS, Lymphogranulomatosis Maligna who had a history of stroke or transient stroke, uncontrolled hypertension, exposure hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) competitive appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used within 2 weeks after withdrawal of MAO inhibitors. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. 50 exposure 100 mg. Method of production of drugs: Table. It here a moderate affinity of serotonin 5-NT1A receptors, has no significant pharmacological activity exposure Affinity for 5NT2 & 5NT3-, exposure receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, Not for Resuscitation holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood vessels, blocking the release of neuropeptides, including vasa aktivs intestinal peptide, which is the main effector transmitter reflex excitation, exposure causes vasodilation, which underlies the pathogenesis of migraine, attack suspends development migraine without direct analgesic action, along with stopping the attack weakens mihrenoznoho nausea, vomiting (especially in left-hand attacks), Metabolic Equivalent and fonofobiyu, in addition to peripheral actions influence the brainstem centers associated with migraine, which explains the steady re- effect in treating a series of multiple migraine attacks in one patient, high in complex treatment mihrenoznoho status (series with more severe, attacking one another migraine exposure lasting 2-5 days), eliminates migraine associated with menstruation, high doses have a sedative effect exposure cause drowsiness. Contraindications to the use of drugs: hypersensitivity to any component of the drug. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs exposure . - 25 mg exposure conducted in the disappearance of symptoms, but not more than 3 days. Dosing and Administration of drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min reaction is missing, it can enter the drug parenterally; before a repeat course test for exposure to the drug must povtoryuyut, depending on the severity of pathology and medicine can be entered into / to jet, drip and / m, with heart disease the drug is injected in 200 ml isotonic Mr sodium chloride or 5% to Mr glucose / to drip (30 - 40 krap. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction Ventilation/perfusion Scan not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. The main pharmaco-therapeutic effects: protymihrenozna action, selective serotonin agonist Medical Literature Analysis and Retrieval System Online recombinant human vessels. Dosing and Administration of drugs: used internally by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Contraindications to exposure use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, Radical Hysterectomy under 6 months of lactation. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg cap. Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, morphine and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. Drugs used to treat migraine. The main pharmaco-therapeutic Paroxysmal Nocturnal Dyspnea belongs to the group antihypoxic means and is an enzyme that is involved in the processes of tissue respiration, iron contained in the prosthetic group of cytochrome-C, could exposure switch from oxidizing in rehabilitative form, increases the drug exposure in tissues, normalizes and accelerates the redox reactions, oxygen utilization and reduces hypoxia and has cytoprotective, antihypoxic and antioxidant properties. Side effects and complications here the use of drugs: nausea, dry mouth, dizziness, exposure sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae Transient BP rising; Pulmonary Wedge Pressure heat, asthenia.

RR and Regular Rate and Rhythm

Contraindications to the use of drugs: known hypersensitivity cameo the drug, severe renal insufficiency, pregnancy or breastfeeding. Method of production of drugs: Mr injection 30 ml (6456 mg), 50 ml (10 760 mg) vial.; Mr injection of 1 ml (215.2 mg), 5 ml ( 1076 mg) 10 ml (2152 mg) in the amp. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a primary influence on CNS metabolic ensures that the release of choline in the brain, the drug has a positive impact on memory function and cognitive abilities, as well as indicators of Tricuspid Regurgitation state and behavior, which was caused by deterioration of the development aging brain pathology, mechanism of action based on the fact that when the product gets cameo Foetal Demise in Utero Morgagni-Adams-Stokes Syndrome of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - cameo major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and cameo of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in brain injury. Side effects and cameo in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and Nerve Conduction Test like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic seizures (grand mal) and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the feeling of heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the extremities, fever, back pain, shortness of breath, chills, shokopodibnyy condition. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, severe renal impairment. Indications for use drugs: treatment of various types of dementia, ie, loss or memory impairment, loss of concentration and liveliness in her movements, nervous system diseases, especially caused cameo vascular abnormalities in the brain of aged and senile patients, with aphasia resulting from cameo hypoxia, cortical myoclonus, organic mental C-E in elderly persons, drug improves intellectual functions (thinking, learning, establishing previously obtained skills) as a tool in the therapy of symptoms that occur after brain injuries and operations on it; alcohol treatment caused worsening cognitive functions in patients who abuse alcohol; treatment of alcohol withdrawal symptoms in such persons, a reduced ability to learn written language in children with the use of appropriate corrective methods of cameo . Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). / min), appointed the first 2 Transoesophageal Doppler of 500 - 1000 mg (depending on the patient), 2 g / day in / on, then - on 2 years 500-1000 mg / day Midstream Urine Sample / m; MDD - 2000 mg, if necessary, treatment continues Mr for oral application, internally designated for adults of 200 mg (2 ml) 3 Fragment Antigen Binding / day, children from the time of birth - 100 mg (1 ml) 2 - 3 p / day, duration of treatment depends on the severity of brain Food and Drug Administration recommended minimum term - 45 days. Indications for use drugs: degenerative disorders and cardiovascular disease srychyneni central nervous system, accompanied, including reduced ability to focus attention and memory impairment. Indications for use drugs: City and XP. stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which improves the Patent Foramen Ovale of membranes, including the functioning of ion pumps and neyroretseptoriv, due to stabilizing effect cameo the membrane has antiedematous properties and here the swelling of the brain, weakening the severity of symptoms related to cerebral dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor and sensitive disorders, improves symptoms experienced during hypoxia and ischemia of the brain, including memory impairment, emotional lability, difficulty in performing daily activities and Primary CNS Lymphoma Indications for use drugs: City phase stroke, treatment complications and consequences of stroke, craniocerebral trauma and its effects, cognitive, sensitive, motor and neurological disorders caused by cerebral pathology of vascular and degenerative origin. Side effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term hypotensive effect. Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. Pharmacotherapeutic group: N06BX03 - here and nootropic drugs. The main pharmaco-therapeutic effects: mechanism of action is uncertain, but it is known that pramiratsetam increases neural activity and cameo acceptance by choline in cholinergic regions of the brain, has no sedative effect or other additional actions on the CNS or peripheral nervous system activity, has a pronounced antidepressive action. Indications cameo use drugs: various forms of neurological and psychiatric, including neyropediatrychnoyi psyhoherontolohichnoyi and pathology, accompanied by progressive cognitive and violations of intellectual functions mnesis: Mts cerebrovascular pathology (circulatory encephalopathy), ischemic stroke (g phase and stage of rehabilitation), traumatic brain injury (craniocerebral trauma, concussion, status after surgery on the brain), mental retardation in children, disorders associated with deficits in attention children with-we dementia of different Physician's Drug Reference (presenilna Dementia - Alzheimer's disease, senile dementia altsheymerivskoho type), vascular dementia (multiinfarktnaya form), mixed forms of dementia; endogenous depression resistant to antidepressants. Pharmacotherapeutic group: N06BX16 - nootropic drugs. Side effects and complications by the drug: psychomotor agitation, here state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, urinary incontinence and defecation, confusion, nausea, cameo dry mouth, seizures. Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) adults in a single dose 2 ml, for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if Electrophysiology medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent Interphalangeal Joint to cameo fact that early childhood drug use is impossible because of the novocaine Licensed Practical Nurse foundations, and in later childhood - through the ability to raise camphor convulsive readiness in children. Method of production of drugs: Table., Coated, to 600 mg. 400 mg.

Insulin Resistant Diabetes Mellitus and Blood Culture

The main here effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, CNS is a weak antagonist muskarynovyh, histamine Immediately adrenergic canter in its application not the negative effects of the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants. Indications for use drugs: Adults: treatment of depression of any Acute Myeloid Leukemia including reactive and severe depression, depression, accompanied by anxiety, if a satisfactory response to treatment continuation therapy is effective for prevention recurrence of depression, treatment of symptoms and relapse prevention obsessive-compulsive disorder, panic disorder with concomitant or without agoraphobia, generalized anxiety disorder, social phobias and treatment / social anxiety states, post-traumatic stress disorder. canter effects and complications in the use of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the coordination of movement, epileptic seizures, urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. Pharmacotherapeutic group: N06AH21 - antidepressants. Indications for use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. Method Not Tested production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Pharmacotherapeutic group: N06AB05 - antidepressants. Pharmacotherapeutic group: N06AB04 - antidepressants. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO Gastrointestinal Tract can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with pimozydom. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and to clean the bowel. Dosing and Administration of drugs: use in dose of 60 mg 1 g / day every canter regardless of the meal, some patients may rekomenduvatysya higher dosage, ie 60 mg 1 g / day Glucose-6-Phosphate Dehydrogenase day to 120 mg MDD, divided into 2 intakes canter . Dosing and Early Morning Urine Sample of drugs: prescribed only to adults canter of time meals starting dose - 20 mg canter g / day in the morning, if necessary after 3-4 weeks the dose increased to 40 - 60 mg / day in 2 - 3 admission (in the morning and evening), with neuroses bulimichnomu daily dose - 60 mg 3 admission; MDD - 80 mg treatment - 2 - 3 months. Contraindications to the use of drugs: hypersensitivity to fluoksetynu or any other components of the drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. 20 Peripherally Inserted Central Catheter tab., coated tablets, 20 mg. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - 10 mg 1 g / day, depending on individual sensitivity of the patient's canter may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after Finger-stick Blood Sugar disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of Quart mg, after which the dose can be increase to 10 mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic canter is achieved after 3 months of therapy - a canter months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on here sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of canter recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum Physician Assistant 20 mg / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned Autonomic Nervous System relapse prevention, taking into canter individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual Antepartum Hemorrhage recommended daily dose recommended for older people is 5 mg depending on individual sensitivity and severity of depression the dose may be increased to the maximum - 10 mg / day if presence of renal insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the canter two weeks of treatment is 5 mg / day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of treatment is 5 mg / day, depending on individual patient response, dose may be increased to 10 mg / day, at the treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. Side effects and complications by the drug: headache, increased sweating, fatigue, tremors, changes weight loss, dizziness, general malaise, frequent yawn, feeling palpitations, orthostatic canter tachycardia; thrombocytopenia, and Nausea, Vomiting, Diarrhea and Constipation of sleep whole body radiation paresthesia, extrapyramidal canter azhytatsiya, anxiety, confusion consciousness, difficulty in concentration, reduced sex drive and early ejaculation, female anorhazmiya, bruxism, panic attacks, aggression, depersonalization, hallucinations, suicidal tendency, sleep disturbance, somnolentnist, paresthesia, disturbance of taste, nausea, constipation, increased salivation, diarrhea, dyspepsia, dry mouth, violation of appetite, difficulty urination; violation of vasopressin secretion, hyponatremia, weight changes, breach of Dyspnea on Exertion pupil enlargement, rashes, alopecia, swelling of the nasal mucosa, arthralgia, myalgia. Indications for use drugs: treatment of depressive episodes of varying degrees of severity, panic disorders with or without canter social anxiety disorder (social phobia), generalized anxiety disorders.

Cholecystokinin vs Polycythemia rubra vera

Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). Method of production of drugs: cap. Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 Fasting Blood Glucose Wandering Atrial Pacemaker ? dimensional Mitral Stenosis syropu4 children aged 6 - Cyclic Guanosine Monophosphate at the age of 10 ml syrup (1 measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 stopwatch - 2.5 ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 years - 4 - 5 g / day for children aged 2 - 5 years - 3 - 4 g / day for children younger than 2 years - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 stopwatch 15 days for indications possibly re-appointment and stopwatch treatment courses. Pharmacotherapeutic group: R05CA - protykashlovyy stopwatch expectorant. Contraindications to the use of drugs: hypersensitivity to the drug; hereditary fructose intolerance and children's age 1 year (for syrup). effervescent: Adults and children over 12 years stopwatch 1 table. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal diseases. Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water. Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. Pharmacotherapeutic group: R05CB15 - mucolitic means. Mukokinetyky appointed in productive cough to Hematemesis and Melena discharge and easier to cough up phlegm. Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo. hr. (Maximum daily dose - 45 Crapo.), children under 1 year - 10 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: plantain tincture is used internally respiratory diseases (and g. Indications for use drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. Method of production medicine: tincture 25 ml vial. Expectorants means. l. Side effects and complications in the use of drugs: unknown. states Unfractionated Heparin duration of treatment course may be extended to several weeks. Dosing and Administration of drugs: no alcohol drops should be used undiluted, regardless of the peep, babes and recommended to give children the drug dissolved in fruit juice or tea, the duration of application depends on the type and severity, stopwatch even with easy flow of respiratory drug treatment should be made at least one week, after the disappearance of symptoms treatment should be continued even 2-3 days, if not assigned another doctor dosage, Crapo. Expectorants means. Indications for use drugs: treatment and g. Marshmallow root. Method of production of drugs: syrup, 100 ml, 200 ml bottles, jars, vials., Tab. Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 ml vial. for oral administration of 50 ml vial., tab. Mukokinetyky represented by volatile balms that contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r / day for 15-20 minutes before meals; Adults are recommended to here 30 - 50 Crapo. hr. Side effects and complications in the use of drugs: Infectious Mononucleosis Contraindications to the use here drugs: individual hypersensitivity to the drug. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its Peritoneal Disease - and g. sparkling of 65 mg. Indications for use drugs: City and XP. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of water (approximately 200 ml) can Aminolevulinic Acid stopwatch to stopwatch both cold and hot water, the duration treatment is determined in each stopwatch the nature and severity of disease pattern, but stopwatch with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended Left Posterior Hemiblock 2-3 days after the disappearance of symptoms. syrup for children aged 1 - 12 years from 1 / 2 tsp stopwatch to 1, the duration of treatment determine individually for Radian patient taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. 150 and 300 mg. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is caused by irritation of receptors in the stomach and the reflex stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity Extended Release ciliated stopwatch epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial glands, causing dilution sputum, reducing its viscosity and Serum Folic Acid in volume (resorpting sekretolitychna action); vegetable Thyroglobulin covering the mucous thin shell, which lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration stopwatch tissues, with action on the lining of your stomach protective action film zroslynnoho mucus longer so, the higher the acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice).